Risk Factors for Rapid Recurrence of Hyperkalemia following Cessation of Sodium Zirconium Cyclosilicate

Background: Sodium zircon`ium cyclosilicate (SZC), a recently introduced potassium binder, is indicated to treat hyperkalemia. SZC is often terminated soon after the normalization of hyperkalemia in real-world clinical practice. We aimed to investigate the risk factors for the rapid recurrence of hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Narang, Nikhil, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739319/
https://www.ncbi.nlm.nih.gov/pubmed/36498671
http://dx.doi.org/10.3390/jcm11237096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739319/
https://www.ncbi.nlm.nih.gov/pubmed/36498671
http://dx.doi.org/10.3390/jcm11237096

Ejemplares similares